Today, the CSC joined the Academic Drug Discovery Consortium, “a professional society dedicated to building the community of academic drug discovery labs and the companies, universities, and government agencies that support and partner with these centers.” It connects us with over 150 drug discovery centers in 17 countries. Michelle Arkin, our external advisory board member, is on the board of directors, and Barbara Slusher, the head of a similar high throughput core facility at my alma mater, Johns Hopkins, is a founding member.